Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

Cardiac Intensive Care Unit lowest heart attack rates in the state of Texas

That’s because the CICU he runs has the lowest myocardial infarction (heart attack) mortality in the entire South Texas region. It has one of the lowest rates in the state of Texas.

23 Apr 2004

FDA recommends approval of stenting to prevent stroke

Cordis Endovascular today reported the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) recommended approval of the company's new Cordis Carotid System. Cordis Endovascular is a division of Cordis Corporation, a Johnson & Johnson company.

21 Apr 2004

GE Introduces new imaging solution for diagnosing certain diseases

Patients can now experience increased peace-of-mind and enhanced expert care during cardiac and vascular treatment, thanks to a first-of-its-kind imaging system from GE Healthcare.

21 Apr 2004

Two recent innovations look set to revolutionize biomedical treatment.

The first innovation is probably the world’s first multiple drug-eluting biodegradable stent for use in any part of the body where fluid flow, including blood, is disrupted.

19 Apr 2004

Coronary stent drives Johnson & Johnson to record profits

Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.

13 Apr 2004

Patients with coronary artery blockages can be treated safely using drug coated stents

The researchers followed 155 consecutive patients treated with multiple sirolimus-eluting stents between April 2002 and March 2003. Each patient had at least two lesions blocking blood flow in different coronary arteries. Earlier studies have demonstrated that patients with a single, simple artery narrowing held open with a sirolimus-eluting stent are less likely to need retreatment than similar patients who received a bare metal stent. However, those studies excluded patients with complex or multiple artery lesions.

6 Apr 2004

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

Cordis Cardiology, a division of Cordis Corporation, a Johnson & Johnson Company, reported today that it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding FDA's observations concerning the Good Manufacturing Practice (GMP) regulations.

5 Apr 2004

Stenting for Stroke Prevention is More Effective Than Surgery in Keeping Blood Vessels Open

Research presented in a six-hour symposium on carotid artery disease at the 29th Annual Scientific Meeting of the Society of Interventional Radiology showed carotid artery stenting to be safe and effective for highrisk patients. Currently, the standard of care for stroke prevention in patients with moderate to severely blocked carotid arteries is carotid endarterectomy surgery. The ARCHeR trials treated patients who were high-risk surgical candidates with carotid artery stenting with and without embolic protection, a device to capture debris that may break off during the procedure.

25 Mar 2004

New treatment for heart attacks

A team led by scientists at The Scripps Research Institute has developed a potential new treatment for heart attacks. The therapy inhibits fluid leakage from cardiac blood vessels following a heart attack and thereby significantly prevents long-term heart damage and improves survival.

22 Mar 2004